Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PUMA BIOTECHNOLOGY, INC. Director's Dealing 2011

Oct 6, 2011

33488_dirs_2011-10-06_2c332b6d-9752-442e-be97-657ddddf72ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (NONE)
CIK: 0001401667
Period of Report: 2011-10-04

Reporting Person: SIDDIQI FARAAZ (Former Secretary and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-04 Common Stock, par value $0.0001 D 1000000 $0.0133 Disposed 0 Direct

Footnotes

F1: On October 4, 2011, the Issuer repurchased from the Reporting Person an aggregate of 1,000,000 shares of common stock of the Issuer at a per share purchase price equal to $0.0133.